Nebraska Cancer Specialists Oncology Hematology West — Omaha, Nebraska

Nebraska Cancer Specialists Oncology Hematology West is a clinical research site located in Omaha, Nebraska, United States 68154.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialists Oncology Hematology West has participated in 2 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors, Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialists Oncology Hematology West?

Nebraska Cancer Specialists Oncology Hematology West has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialists Oncology Hematology West conducted?

Nebraska Cancer Specialists Oncology Hematology West has 2 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Breast Cancer.

Is Nebraska Cancer Specialists Oncology Hematology West accredited by Crixeo Health?

Nebraska Cancer Specialists Oncology Hematology West has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialists Oncology Hematology West?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.